[Current treatment of acute leukemia]. 1966

J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
February 1978, Comprehensive therapy,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
May 1968, Nederlands tijdschrift voor geneeskunde,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
March 1967, Semaine therapeutique,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
October 2012, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
March 2007, Haematologica,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
November 2012, Current opinion in oncology,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
April 2000, Indian pediatrics,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
June 2021, Blood cancer journal,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
December 2011, Frontiers of medicine,
J Bernard, and M Boiron, and C Jacquillat, and Y Najean, and M Seligmann, and J Tanzer, and M Weil
January 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!